ISRV Epidemiology Group
@isirvepi.bsky.social
The ISRV Epidemiology Group aims to promote the scientific understanding of how respiratory viruses spread in populations.
Reposted by ISRV Epidemiology Group
You can also find more information about #RSV on the European Vaccination Information Portal - #EVIP in YOUR language!
Check it out here: vaccination-info.europa.eu/en/rsv
#UnitedInProtection #VaccinesSaveLives #VaccinesWork #ChildHealth #PublicHealth
Check it out here: vaccination-info.europa.eu/en/rsv
#UnitedInProtection #VaccinesSaveLives #VaccinesWork #ChildHealth #PublicHealth
RSV
Key facts on RSV symptoms, complications, risk factors, how it spreads, prevention, vaccination and treatment.
vaccination-info.europa.eu
November 13, 2025 at 2:53 PM
You can also find more information about #RSV on the European Vaccination Information Portal - #EVIP in YOUR language!
Check it out here: vaccination-info.europa.eu/en/rsv
#UnitedInProtection #VaccinesSaveLives #VaccinesWork #ChildHealth #PublicHealth
Check it out here: vaccination-info.europa.eu/en/rsv
#UnitedInProtection #VaccinesSaveLives #VaccinesWork #ChildHealth #PublicHealth
Reposted by ISRV Epidemiology Group
📢 Call for Abstracts!
Submit your abstracts for SHEA Spring 2026 by January 13, 2026, at 11:59 p.m. ET.
Don’t miss your chance to share your research with leaders in healthcare epidemiology and infection prevention.
bit.ly/4qNoqNU
Submit your abstracts for SHEA Spring 2026 by January 13, 2026, at 11:59 p.m. ET.
Don’t miss your chance to share your research with leaders in healthcare epidemiology and infection prevention.
bit.ly/4qNoqNU
November 7, 2025 at 10:00 AM
📢 Call for Abstracts!
Submit your abstracts for SHEA Spring 2026 by January 13, 2026, at 11:59 p.m. ET.
Don’t miss your chance to share your research with leaders in healthcare epidemiology and infection prevention.
bit.ly/4qNoqNU
Submit your abstracts for SHEA Spring 2026 by January 13, 2026, at 11:59 p.m. ET.
Don’t miss your chance to share your research with leaders in healthcare epidemiology and infection prevention.
bit.ly/4qNoqNU
Reposted by ISRV Epidemiology Group
One week to go! Abstract submissions for Annual Conference 2026 close at 23:59 GMT on Tuesday 11 November. If you study microbes, there’s a home for your work at #Microbio26
Submit your work to one of >20 available sessions at: microb.io/AC26Abstracts
Submit your work to one of >20 available sessions at: microb.io/AC26Abstracts
November 4, 2025 at 11:01 AM
One week to go! Abstract submissions for Annual Conference 2026 close at 23:59 GMT on Tuesday 11 November. If you study microbes, there’s a home for your work at #Microbio26
Submit your work to one of >20 available sessions at: microb.io/AC26Abstracts
Submit your work to one of >20 available sessions at: microb.io/AC26Abstracts
Reposted by ISRV Epidemiology Group
🚨 Only 2 weeks left to apply! Pasteur Course: The Last Mile – Towards Elimination of Major Infectious Diseases
Join a unique intensive course tackling the current challenges and critical advances in the fight against infectious diseases.
👉 Register now before November 22! bit.ly/4r1RpxE
Join a unique intensive course tackling the current challenges and critical advances in the fight against infectious diseases.
👉 Register now before November 22! bit.ly/4r1RpxE
November 7, 2025 at 10:05 AM
🚨 Only 2 weeks left to apply! Pasteur Course: The Last Mile – Towards Elimination of Major Infectious Diseases
Join a unique intensive course tackling the current challenges and critical advances in the fight against infectious diseases.
👉 Register now before November 22! bit.ly/4r1RpxE
Join a unique intensive course tackling the current challenges and critical advances in the fight against infectious diseases.
👉 Register now before November 22! bit.ly/4r1RpxE
Reposted by ISRV Epidemiology Group
Last chace to register for this year's Influenza Update Meeting - and places are going fast. Don't miss out!
Looking forward to seeing you there, flu people
Looking forward to seeing you there, flu people
REGISTRATION NOW OPEN
Influenza Update 2025
University of Warwick, 15th - 16th December
warwick.ac.uk/fac/sci/med/...
Registration from £50 - £120
DEADLINE: 7th November
We hope you can join us there!
Influenza Update 2025
University of Warwick, 15th - 16th December
warwick.ac.uk/fac/sci/med/...
Registration from £50 - £120
DEADLINE: 7th November
We hope you can join us there!
November 5, 2025 at 1:17 PM
Last chace to register for this year's Influenza Update Meeting - and places are going fast. Don't miss out!
Looking forward to seeing you there, flu people
Looking forward to seeing you there, flu people
Reposted by ISRV Epidemiology Group
Getting--or got--a PhD? Got boogie in your soul? Then don't be shy. Enter this year's contest--and dance, dance, dance! @science.org
Science’s ‘Dance Your Ph.D.’ contest is open again—with an all new, AI twist
For the first time, there’s a special prize for a research-themed dance generated by an artificial intelligence program
www.science.org
November 5, 2025 at 1:45 PM
Getting--or got--a PhD? Got boogie in your soul? Then don't be shy. Enter this year's contest--and dance, dance, dance! @science.org
Reposted by ISRV Epidemiology Group
How can public engagement transform how we teach #Immunology?
Join this parallel session organised by the BSI Teaching Affinity Group at BSI Congress to explore how collaboration and lived experience enrich education & research.
Register for #BSI25: https://bit.ly/3IkxWq8
Join this parallel session organised by the BSI Teaching Affinity Group at BSI Congress to explore how collaboration and lived experience enrich education & research.
Register for #BSI25: https://bit.ly/3IkxWq8
November 5, 2025 at 11:35 AM
How can public engagement transform how we teach #Immunology?
Join this parallel session organised by the BSI Teaching Affinity Group at BSI Congress to explore how collaboration and lived experience enrich education & research.
Register for #BSI25: https://bit.ly/3IkxWq8
Join this parallel session organised by the BSI Teaching Affinity Group at BSI Congress to explore how collaboration and lived experience enrich education & research.
Register for #BSI25: https://bit.ly/3IkxWq8
Reposted by ISRV Epidemiology Group
#ESWI2025 I #ScienceCommunication #Trust #RiskCommunication #PublicHealth
Frédéric Bouder @unistavanger.bsky.social 🇳🇴
✅ Effective communication of benefits and risks is a key factor in building #Trust
🧭 The three pillars of #Trust: Fairness, Competence, Efficiency
Frédéric Bouder @unistavanger.bsky.social 🇳🇴
✅ Effective communication of benefits and risks is a key factor in building #Trust
🧭 The three pillars of #Trust: Fairness, Competence, Efficiency
October 22, 2025 at 11:17 AM
#ESWI2025 I #ScienceCommunication #Trust #RiskCommunication #PublicHealth
Frédéric Bouder @unistavanger.bsky.social 🇳🇴
✅ Effective communication of benefits and risks is a key factor in building #Trust
🧭 The three pillars of #Trust: Fairness, Competence, Efficiency
Frédéric Bouder @unistavanger.bsky.social 🇳🇴
✅ Effective communication of benefits and risks is a key factor in building #Trust
🧭 The three pillars of #Trust: Fairness, Competence, Efficiency
Reposted by ISRV Epidemiology Group
📜 At #ESWI2025 Maria Zambon traces the history of how we understand pandemics — from religious interpretations to the rise of rational, evidence-based therapeutics
A fascinating look at how science reshaped our view of disease and response🧠
#PublicHealth #Pandemic #History
A fascinating look at how science reshaped our view of disease and response🧠
#PublicHealth #Pandemic #History
October 23, 2025 at 6:39 AM
📜 At #ESWI2025 Maria Zambon traces the history of how we understand pandemics — from religious interpretations to the rise of rational, evidence-based therapeutics
A fascinating look at how science reshaped our view of disease and response🧠
#PublicHealth #Pandemic #History
A fascinating look at how science reshaped our view of disease and response🧠
#PublicHealth #Pandemic #History
Reposted by ISRV Epidemiology Group
ESCAIDE 2025 is just around the corner! We are looking forward to seeing you in Warsaw or online on 19-21 November.
You can still register to join us virtually: lnkd.in/dHvsXxqr
Get a preview of our programme featuring key topics in public health and epidemiology: lnkd.in/d6ZM-ZYT
You can still register to join us virtually: lnkd.in/dHvsXxqr
Get a preview of our programme featuring key topics in public health and epidemiology: lnkd.in/d6ZM-ZYT
October 15, 2025 at 9:39 AM
ESCAIDE 2025 is just around the corner! We are looking forward to seeing you in Warsaw or online on 19-21 November.
You can still register to join us virtually: lnkd.in/dHvsXxqr
Get a preview of our programme featuring key topics in public health and epidemiology: lnkd.in/d6ZM-ZYT
You can still register to join us virtually: lnkd.in/dHvsXxqr
Get a preview of our programme featuring key topics in public health and epidemiology: lnkd.in/d6ZM-ZYT
Reposted by ISRV Epidemiology Group
Vaccination against herpes zoster, or shingles, is linked to lower risks of heart disease, dementia and death in people age 50 and older, according to new research presented at #IDWeek2025. https://bit.ly/471biNp
Shingles Vaccine Lowers Risk of Dementia, Major Cardiovascular Events
bit.ly
October 20, 2025 at 11:37 AM
Vaccination against herpes zoster, or shingles, is linked to lower risks of heart disease, dementia and death in people age 50 and older, according to new research presented at #IDWeek2025. https://bit.ly/471biNp
Reposted by ISRV Epidemiology Group
✈️ Next stop: #ESWI2025 in Valencia!
We’re excited to join global experts in infectious disease control, antimicrobial stewardship, and vaccine innovation.
Looking forward to sharing insights, forging collaborations, and advancing prevention together.
#VIVI #InfectionPrevention
We’re excited to join global experts in infectious disease control, antimicrobial stewardship, and vaccine innovation.
Looking forward to sharing insights, forging collaborations, and advancing prevention together.
#VIVI #InfectionPrevention
October 19, 2025 at 2:35 PM
✈️ Next stop: #ESWI2025 in Valencia!
We’re excited to join global experts in infectious disease control, antimicrobial stewardship, and vaccine innovation.
Looking forward to sharing insights, forging collaborations, and advancing prevention together.
#VIVI #InfectionPrevention
We’re excited to join global experts in infectious disease control, antimicrobial stewardship, and vaccine innovation.
Looking forward to sharing insights, forging collaborations, and advancing prevention together.
#VIVI #InfectionPrevention
Reposted by ISRV Epidemiology Group
⏰#ERSCongress ALERT
📰 Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial
🔓 Online now and free to access for all: tinyurl.com/4nhbtj89
📰 Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial
🔓 Online now and free to access for all: tinyurl.com/4nhbtj89
September 28, 2025 at 7:28 AM
⏰#ERSCongress ALERT
📰 Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial
🔓 Online now and free to access for all: tinyurl.com/4nhbtj89
📰 Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial
🔓 Online now and free to access for all: tinyurl.com/4nhbtj89
Reposted by ISRV Epidemiology Group
Long Covid Risk for Children Doubles After a Second Infection, Study Finds.
Children you say?
#longCOVID
www.nytimes.com/2025/09/30/h...
Children you say?
#longCOVID
www.nytimes.com/2025/09/30/h...
Long Covid Risk for Children Doubles After a Second Infection, Study Finds
www.nytimes.com
October 1, 2025 at 3:09 AM
Long Covid Risk for Children Doubles After a Second Infection, Study Finds.
Children you say?
#longCOVID
www.nytimes.com/2025/09/30/h...
Children you say?
#longCOVID
www.nytimes.com/2025/09/30/h...
Reposted by ISRV Epidemiology Group
Spaces are filling fast! Register for our bioinformatics training starting Monday 20 October 👉 bit.ly/4emxfIt
⏰ Don’t miss out! Our 'Single cell & spatial analysis' bioinformatics training course starts Monday 20 October.
✔️ Hands-on R training
✔️ 3,000+ past attendees
✔️ 9.5/10 rating
Only a few places left – secure yours today! https://bit.ly/4nnlTaN
✔️ Hands-on R training
✔️ 3,000+ past attendees
✔️ 9.5/10 rating
Only a few places left – secure yours today! https://bit.ly/4nnlTaN
September 16, 2025 at 11:51 AM
Spaces are filling fast! Register for our bioinformatics training starting Monday 20 October 👉 bit.ly/4emxfIt
Reposted by ISRV Epidemiology Group
Thank you for joining @promedmail.org’s 31st anniversary! Your support helps us strengthen systems, better serve our users, and continue sharing trusted outbreak alerts worldwide.
Here’s to many more years protecting global health ✨ #ISID
ow.ly/En2C50WGWqm
Here’s to many more years protecting global health ✨ #ISID
ow.ly/En2C50WGWqm
September 2, 2025 at 8:02 PM
Thank you for joining @promedmail.org’s 31st anniversary! Your support helps us strengthen systems, better serve our users, and continue sharing trusted outbreak alerts worldwide.
Here’s to many more years protecting global health ✨ #ISID
ow.ly/En2C50WGWqm
Here’s to many more years protecting global health ✨ #ISID
ow.ly/En2C50WGWqm
Reposted by ISRV Epidemiology Group
Microbial communities of grapevines vary between wine regions, grape variety, climate, geography and vineyard practices. 🍇
This #FEMSmicroBlog explains how the well-adapted yeast species Hanseniaspora shapes grape fermentation and thus the final wine product. #FascinatingMicrobes
This #FEMSmicroBlog explains how the well-adapted yeast species Hanseniaspora shapes grape fermentation and thus the final wine product. #FascinatingMicrobes
#FEMSmicroBlog: Revealing the hidden diversity of wine yeasts
This #FEMSmicroBlog explains how the well-adapted yeast species Hanseniaspora shapes grape fermentation and thus the final wine product. #FascinatingMicrobes
buff.ly
September 16, 2025 at 8:28 AM
Microbial communities of grapevines vary between wine regions, grape variety, climate, geography and vineyard practices. 🍇
This #FEMSmicroBlog explains how the well-adapted yeast species Hanseniaspora shapes grape fermentation and thus the final wine product. #FascinatingMicrobes
This #FEMSmicroBlog explains how the well-adapted yeast species Hanseniaspora shapes grape fermentation and thus the final wine product. #FascinatingMicrobes
Reposted by ISRV Epidemiology Group
🌍 At @ESCMID #VaccinesConference in Lisbon, #Pandemic #Preparedness is in focus (Day 3 & Day 5).
From surveillance to vaccines, global cooperation is key to staying ahead of future threats.
Prevention today means resilience tomorrow.
#UnitedInProtection
👉 bit.ly/ViVI-Prep2025
From surveillance to vaccines, global cooperation is key to staying ahead of future threats.
Prevention today means resilience tomorrow.
#UnitedInProtection
👉 bit.ly/ViVI-Prep2025
September 12, 2025 at 1:02 PM
🌍 At @ESCMID #VaccinesConference in Lisbon, #Pandemic #Preparedness is in focus (Day 3 & Day 5).
From surveillance to vaccines, global cooperation is key to staying ahead of future threats.
Prevention today means resilience tomorrow.
#UnitedInProtection
👉 bit.ly/ViVI-Prep2025
From surveillance to vaccines, global cooperation is key to staying ahead of future threats.
Prevention today means resilience tomorrow.
#UnitedInProtection
👉 bit.ly/ViVI-Prep2025
Reposted by ISRV Epidemiology Group
Did you know the next pandemic is likely to emerge from one of 25 or so viral families?
Learning as much as possible about them now & building a library of knowledge is helping scientists get ahead of this threat.
Discover the families in CEPI's The Viral Most Wanted ➡️ cepi.net/viral-most-w...
Learning as much as possible about them now & building a library of knowledge is helping scientists get ahead of this threat.
Discover the families in CEPI's The Viral Most Wanted ➡️ cepi.net/viral-most-w...
September 12, 2025 at 1:09 PM
Did you know the next pandemic is likely to emerge from one of 25 or so viral families?
Learning as much as possible about them now & building a library of knowledge is helping scientists get ahead of this threat.
Discover the families in CEPI's The Viral Most Wanted ➡️ cepi.net/viral-most-w...
Learning as much as possible about them now & building a library of knowledge is helping scientists get ahead of this threat.
Discover the families in CEPI's The Viral Most Wanted ➡️ cepi.net/viral-most-w...
Reposted by ISRV Epidemiology Group
📰The Lancet Respiratory Medicine’s September issue is out now
Read content on obstructive sleep apnoea, #tuberculosis, cardiogenic shock, #pneumonia, and much more
Check out the full issue here: bit.ly/3P2PVls
Read content on obstructive sleep apnoea, #tuberculosis, cardiogenic shock, #pneumonia, and much more
Check out the full issue here: bit.ly/3P2PVls
September 1, 2025 at 1:57 PM
📰The Lancet Respiratory Medicine’s September issue is out now
Read content on obstructive sleep apnoea, #tuberculosis, cardiogenic shock, #pneumonia, and much more
Check out the full issue here: bit.ly/3P2PVls
Read content on obstructive sleep apnoea, #tuberculosis, cardiogenic shock, #pneumonia, and much more
Check out the full issue here: bit.ly/3P2PVls
Reposted by ISRV Epidemiology Group
New Research:
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
www.thelancet.com/journals/lan...
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
www.thelancet.com/journals/lan...
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
In patients admitted to hospital with COVID-19 pneumonia, sotrovimab was associated
with reduced mortality in the primary analysis population who had a high serum SARS-CoV-2
antigen concentration at b...
www.thelancet.com
August 29, 2025 at 9:15 AM
New Research:
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
www.thelancet.com/journals/lan...
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
www.thelancet.com/journals/lan...
Reposted by ISRV Epidemiology Group
"On the one hand, we have a hypothesis underpinned by evidence, although imperfect, and on the other hand we have a hypothesis without evidence, although it might exist."
Our latest editorial in advance of our August issue
www.thelancet.com/journals/lan...
#IDSky #ClinMicro #ViroSky #SARS-CoV-2
Our latest editorial in advance of our August issue
www.thelancet.com/journals/lan...
#IDSky #ClinMicro #ViroSky #SARS-CoV-2
July 29, 2025 at 11:35 AM
"On the one hand, we have a hypothesis underpinned by evidence, although imperfect, and on the other hand we have a hypothesis without evidence, although it might exist."
Our latest editorial in advance of our August issue
www.thelancet.com/journals/lan...
#IDSky #ClinMicro #ViroSky #SARS-CoV-2
Our latest editorial in advance of our August issue
www.thelancet.com/journals/lan...
#IDSky #ClinMicro #ViroSky #SARS-CoV-2
Reposted by ISRV Epidemiology Group
Response to Letter to the Editor, Re: The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Response to Letter to the Editor, Re: The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study
bit.ly
August 27, 2025 at 7:56 PM
Response to Letter to the Editor, Re: The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Reposted by ISRV Epidemiology Group
For 31 years, @promedmail.org has led the way in reporting major and minor disease outbreaks, like being the first to alert the world to #COVID19. Our experts work around the clock to detect and share outbreak intelligence worldwide. #ISID
Make a gift today: ow.ly/X70M50WGWn4
Make a gift today: ow.ly/X70M50WGWn4
August 21, 2025 at 6:40 PM
For 31 years, @promedmail.org has led the way in reporting major and minor disease outbreaks, like being the first to alert the world to #COVID19. Our experts work around the clock to detect and share outbreak intelligence worldwide. #ISID
Make a gift today: ow.ly/X70M50WGWn4
Make a gift today: ow.ly/X70M50WGWn4
Reposted by ISRV Epidemiology Group
Follow the science: ⬇️
Plan for a world of post-COVID immune effects
These changes are small, but across tens of millions of people, they add up.
canadahealthwatch.ca
August 23, 2025 at 2:20 AM
Follow the science: ⬇️